We are monitoring the impact of COVID-19 on MEA Nuclear Nuclear Medicine/Radiopharmaceuticals Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 109
Share on
Share on

Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Market Research Report – Segmented By Diagnostics, Therapeutics, Application and Country (KSA, UAE, Israel, Rest Of GCC Countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, Rest Of MEA) - Industry Analysis, Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 109
Pages: 145

MEA Nuclear Medicine/Radiopharmaceuticals Market Size (2021 to 2026)

The Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Market size is estimated at USD 0.87 billion in 2021. It is expected to reach USD 2.35 billion by 2026, growing at a CAGR of 22.11% during the forecast period.

Nuclear medicine falls under the field of Molecular Imaging, which involves using a minute amount of radioactive material (radiopharmaceuticals) to diagnose and treat disease.

The increasing incidence of cancer and cardiac ailments, immense technological advancements, increasing demand for SPECT and PET applications, and the growing public awareness for healthcare are fuelling the growth of the Radiopharmaceuticals market. The integration of X-ray tomography (CT) into SPECT has recently emerged as an excellent diagnostic tool in medical imaging. It is considered to be a driving factor for the growth of the market. However, a strict regulatory framework poses a significant hurdle to translational research, and clinical investigations and reimbursement issues are blocking the growth of the Radiopharmaceuticals market. Besides, the short half-life of radiopharmaceuticals and competition from orthodox diagnostic procedures also restrain the Middle-East & Africa nuclear medicine market.

The market of radiopharmaceuticals is dominated by diagnostic radioisotopes and is expected to have a market share of 90 % of the radiopharmaceuticals market, while therapeutic radioisotopes contribute 10% of the market. Based on the type of radioisotopes, the market is segmented into Technetium-99m (TC-99m), Thallium-201 (TL-201), Fluorine-18, Iodine (I-123), Rubidium-82 (RB-82), and others. F-18 FDG tracers mostly contribute to the F-18 market, though it is enriched with future tracers such as F-18 Florbetapir and F-18 Choline. The promising clinical outcome of these tracers has gained the business interest of major research institutes and PET isotope players. Ga-68 and Rb-82 are two other potential isotopes in the PET diagnostic market, ensuring the high growth of the diagnostics segment. Diagnosis of coronary artery disease, bone metastasis, and Alzheimer’s disease is the most promising indication for the future PET radioisotopes market.

This research report on the MEA nuclear medicine market has been segmented and sub-segmented into the following categories:

By Type: 

  • Diagnostic Radioisotopes
    • SPECT   
      • Technetium-99m
      • Thallium-201
      • Gallium-67
      • Iodine-23
      • Others
    • PET     
      • Fluorine-18
      • Rubidium-82
      • Others
  • Therapeutic Radioisotopes                
    • Beta Emitters   
      • Iodine-131
      • Yttrium-90
      • Samarium-153
      • Rhenium-186
      • Lutetium-177
    • Alpha Emitters  
      • Radium-223
    • Brachytherapy  
      • Cesium-131
      • Iodine-125
      • Palladium-103
      • Iridium-192

By Application: 

  • Cardiology
  • Lymphoma
  • Thyroid           
  • Neurology        
  • Oncology         
  • Others

By Country: 

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

KEY MARKET PLAYERS:

A few prominent companies operating in the MEA nuclear medicine market analyzed in this report are GE Healthcare, Hologic Inc., Medix Inc., Segami Corporation, Positron Corporation, Bracco Imaging S.p. A, Naviscan Inc., Bayer Healthcare, Lantheus Medical Imaging, Inc. and IBA Molecular Imaging.

1.Introduction                                                  

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                           

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                              

                2.2 Analysis Design                                         

                2.3 Research Phases                                      

                                2.3.1 Secondary Research                            

                                2.3.2 Primary Research                 

                                2.3.3 Econometric Modelling                     

                                2.3.4 Expert Validation                  

                2.4 Study Timeline                                          

3. Overview                                                      

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                      

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                               

5. Market Segmentation                                                              

                5.1 By Type                                        

                                5.1.1 Diagnostic Radioisotopes                 

                                                5.1.1.1 SPECT    

                                                                5.1.1.1.1 Technetium-99m

                                                                5.1.1.1.2 Thallium-201

                                                                5.1.1.1.3 Gallium-67

                                                                5.1.1.1.4 Iodine-23

                                                                5.1.1.1.5 Others

                                                5.1.1.2 PET         

                                                                5.1.1.2.1 Fluorine-18

                                                                5.1.1.2.2 Rubidium-82

                                                                5.1.1.2.3 Others

                                5.1.2 Therapeutic Radioisotopes                              

                                                5.1.2.1 Beta Emitters     

                                                                5.1.2.1.1 Iodine-131

                                                                5.1.2.1.2 Yttrium-90

                                                                5.1.2.1.3 Samarium-153

                                                                5.1.2.1.4 Rhenium-186

                                                                5.1.2.1.5 Lutetium-177

                                                5.1.2.2 Alpha Emitters   

                                                                5.1.2.2.1 Radium-223

                                                5.1.2.3 Brachytherapy   

                                                                5.1.2.3.1 Cesium-131

                                                                5.1.2.3.2 Iodine-125

                                                                5.1.2.3.3 Palladium-103

                                                                5.1.2.3.4 Iridium-192

                5.2 By Application                                           

                                5.2.1 Cardiology                               

                                5.2.2 Lymphoma                             

                                5.2.3 Thyroid                     

                                5.2.4 Neurology               

                                5.2.5 Oncology                 

                                5.2.6 Others                      

6. Geographical Analysis                                                              

                                6.1 UAE               

                                6.2 Saudi Arabia                               

                                6.3 Israel                             

                                6.4 South Africa               

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                      

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services               

                                7.2.5 Competitive Rivalry within the Industry                      

8.Market Leaders' Analysis                                                          

                8.1 GE Healthcare                                           

                                8.1.1 Overview                

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                            

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Hologic Inc.                                

                8.3 Segami Corporation                                

                8.4 Positron Corporation                                              

                8.5 Bracco Imaging S.P.A                                              

                8.6 Naviscan Inc.                                              

                8.7 Bayer Healthcare                                     

                8.8 Lantheus Medical Imaging Inc.                                           

                8.9 IBA Molecular Imaging                                           

                8.10 Medix Inc.                                

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                        

                9.3 Agreements, collaborations and Joint Ventures                                          

                9.4 New Product Launches                                          

10.Expert Opinions                                                         

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Market, By Region, From 2021 to 2026 (USD Million)
  2. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Market, By Type, From 2021 to 2026 (USD Million)
  3. Middle East & Africa Diagnostic Radioisotopes Market, By Region, From 2021 to 2026 (USD Million)
  4. Middle East & Africa Therapeutic Radioisotopes Market, By Region, From 2021 to 2026 (USD Million)
  5. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Market, By Application, From 2021 to 2026 (USD Million)
  6. Middle East & Africa Cardiology Market, By Region, From 2021 to 2026 (USD Million)
  7. Middle East & Africa Lymphoma Market, By Region, From 2021 to 2026 (USD Million)
  8. Middle East & Africa Thyroid Market, By Region, From 2021 to 2026 (USD Million)
  9. Middle East & Africa Neurology Market, By Region, From 2021 to 2026 (USD Million)
  10. Middle East & Africa Oncology Market, By Region, From 2021 to 2026 (USD Million)
  11. Middle East & Africa Other Applications Market, By Region, From 2021 to 2026 (USD Million)
  12. Middle East & Africa Diagnostic Radioisotopes Market, By Type, From 2021 to 2026 (USD Million)
  13. Middle East & Africa SPECT Diagnostic Radioisotopes Market, By Region, From 2021 to 2026 (USD Million)
  14. Middle East & Africa PET Diagnostic Radioisotopes Market, By Region, From 2021 to 2026 (USD Million)
  15. Middle East & Africa Other Diagnostic Radioisotopes Market, By Region, From 2021 to 2026 (USD Million)
  16. Middle East & Africa SPECT Diagnostic Radioisotopes Market, By Type, From 2021 to 2026 (USD Million)
  17. Middle East & Africa Technetium-99m Market, By Region, From 2021 to 2026 (USD Million)
  18. Middle East & Africa Thallium-201 Market, By Region, From 2021 to 2026 (USD Million)
  19. Middle East & Africa Gallium-67 Market, By Region, From 2021 to 2026 (USD Million)
  20. Middle East & Africa Iodine-23 Market, By Region, From 2021 to 2026 (USD Million)
  21. Middle East & Africa Other SPECT Diagnostic Radioisotopes Market, By Region, From 2021 to 2026 (USD Million)
  22. Middle East & Africa PET Diagnostic Radioisotopes Market, By Type, From 2021 to 2026 (USD Million)
  23. Middle East & Africa Fluorine-18 Market, By Region, From 2021 to 2026 (USD Million)
  24. Middle East & Africa Rubidium-82 Market, By Region, From 2021 to 2026 (USD Million)
  25. Middle East & Africa Other PET Diagnostic Radioisotopes Market, By Region, From 2021 to 2026 (USD Million)
  26. Middle East & Africa Therapeutic Radioisotopes Market, By Type, From 2021 to 2026 (USD Million)
  27. Middle East & Africa Beta Emitters Market, By Region, From 2021 to 2026 (USD Million)
  28. Middle East & Africa Alpha Emitters Market, By Region, From 2021 to 2026 (USD Million)
  29. Middle East & Africa Brachytherapy Market, By Region, From 2021 to 2026 (USD Million)
  30. Middle East & Africa Beta Emitters Market, By Type, From 2021 to 2026 (USD Million)
  31. Middle East & Africa Iodine-131 Market, By Region, From 2021 to 2026 (USD Million)
  32. Middle East & Africa Yttrium-90 Market, By Region, From 2021 to 2026 (USD Million)
  33. Middle East & Africa Samarium-153 Market, By Region, From 2021 to 2026 (USD Million)
  34. Middle East & Africa Rhenium-186 Market, By Region, From 2021 to 2026 (USD Million)
  35. Middle East & Africa Lutetium-177 Market, By Region, From 2021 to 2026 (USD Million)
  36. Middle East & Africa Alpha Emitters Market, By Type, From 2021 to 2026 (USD Million)
  37. Middle East & Africa Radium-223 Market, By Region, From 2021 to 2026 (USD Million)
  38. Middle East & Africa Other Alpha Emitters Market, By Region, From 2021 to 2026 (USD Million)
  39. Middle East & Africa Brachytherapy Market, By Type, From 2021 to 2026 (USD Million)
  40. Middle East & Africa Cesium-131 Market, By Region, From 2021 to 2026 (USD Million)
  41. Middle East & Africa Iodine-125 Market, By Region, From 2021 to 2026 (USD Million)
  42. Middle East & Africa Palladium-103 Market, By Region, From 2021 to 2026 (USD Million)
  43. Middle East & Africa Iridium-192 Market, By Region, From 2021 to 2026 (USD Million)
  44. UAE Nuclear Medicine/Radiopharmaceuticals Market, By Type, From 2021 to 2026 (USD Million)
  45. UAE Nuclear Medicine/Radiopharmaceuticals Market, By Application, From 2021 to 2026 (USD Million)
  46. Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Market, By Type, From 2021 to 2026 (USD Million)
  47. Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Market, By Application, From 2021 to 2026 (USD Million)
  48. Israel Nuclear Medicine/Radiopharmaceuticals Market, By Type, From 2021 to 2026 (USD Million)
  49. Israel Nuclear Medicine/Radiopharmaceuticals Market, By Application, From 2021 to 2026 (USD Million)
  50. South Africa Nuclear Medicine/Radiopharmaceuticals Market, By Type, From 2021 to 2026 (USD Million)
  51. South Africa Nuclear Medicine/Radiopharmaceuticals Market, By Application, From 2021 to 2026 (USD Million)
  52. UAE Diagnostic Radioisotopes Market, By Type, From 2021 to 2026 (USD Million)
  53. Saudi Arabia Diagnostic Radioisotopes Market, By Type, From 2021 to 2026 (USD Million)
  54. Israel Diagnostic Radioisotopes Market, By Type, From 2021 to 2026 (USD Million)
  55. South Africa Diagnostic Radioisotopes Market, By Type, From 2021 to 2026 (USD Million)
  56. UAE SPECT Diagnostic Radioisotopes Market, By Type, From 2021 to 2026 (USD Million)
  57. Saudi Arabia SPECT Diagnostic Radioisotopes Market, By Type, From 2021 to 2026 (USD Million)
  58. Israel SPECT Diagnostic Radioisotopes Market, By Type, From 2021 to 2026 (USD Million)
  59. South Africa SPECT Diagnostic Radioisotopes Market, By Type, From 2021 to 2026 (USD Million)
  60. UAE PET Diagnostic Radioisotopes Market, By Type, From 2021 to 2026 (USD Million)
  61. Saudi Arabia PET Diagnostic Radioisotopes Market, By Type, From 2021 to 2026 (USD Million)
  62. Israel PET Diagnostic Radioisotopes Market, By Type, From 2021 to 2026 (USD Million)
  63. South Africa PET Diagnostic Radioisotopes Market, By Type, From 2021 to 2026 (USD Million)
  64. UAE Therapeutic Radioisotopes Market, By Type, From 2021 to 2026 (USD Million)
  65. Saudi Arabia Therapeutic Radioisotopes Market, By Type, From 2021 to 2026 (USD Million)
  66. Israel Therapeutic Radioisotopes Market, By Type, From 2021 to 2026 (USD Million)
  67. South Africa Therapeutic Radioisotopes Market, By Type, From 2021 to 2026 (USD Million)
  68. UAE Beta Emitters Market, By Type, From 2021 to 2026 (USD Million)
  69. Saudi Arabia Beta Emitters Market, By Type, From 2021 to 2026 (USD Million)
  70. Israel Beta Emitters Market, By Type, From 2021 to 2026 (USD Million)
  71. South Africa Beta Emitters Market, By Type, From 2021 to 2026 (USD Million)
  72. UAE Alpha Emitters Market, By Type, From 2021 to 2026 (USD Million)
  73. Saudi Arabia Alpha Emitters Market, By Type, From 2021 to 2026 (USD Million)
  74. Israel Alpha Emitters Market, By Type, From 2021 to 2026 (USD Million)
  75. South Africa Alpha Emitters Market, By Type, From 2021 to 2026 (USD Million)
  76. UAE Brachytherapy Market, By Type, From 2021 to 2026 (USD Million)
  77. Saudi Arabia Brachytherapy Market, By Type, From 2021 to 2026 (USD Million)
  78. Israel Brachytherapy Market, By Type, From 2021 to 2026 (USD Million)
  79. South Africa Brachytherapy Market, By Type, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample